YARROW BIOSCIENCE, INC. Stock Issued During Period, Shares, Employee Stock Purchase Plans
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- YARROW BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-06-30 was 644.00 shares, a 98.77% increase year-over-year.
- YARROW BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2026-03-31 was 0.00 shares.
- YARROW BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-06-30 was 324.00 shares, a 93.87% decline year-over-year.
- YARROW BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for the quarter ending 2025-03-31 was 0.00 shares.
- YARROW BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2023 was 15.26K shares, a 102.16% increase from fiscal 2022.
- YARROW BIOSCIENCE, INC. stock issued during period, shares, employee stock purchase plans for fiscal 2022 was 7.55K shares.
| Period end | Stock Issued During Period, Shares, Employee Stock Purchase Plans 3 month | Stock Issued During Period, Shares, Employee Stock Purchase Plans 12 month |
|---|---|---|
| 2026-06-30 | 644.00 shares derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | |
| 2026-03-31 | 0.00 shares S-4/A · filed 2026-06-03 | |
| 2025-12-31 | 24.70K shares S-4/A · filed 2026-06-03 | |
| 2025-06-30 | 324.00 shares derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | 9.12K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | 0.00 shares S-4/A · filed 2026-06-03 | 14.08K shares derived: sum of 4 quarters · filed 2026-06-03 |
| 2024-12-31 | 8.79K shares derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | 14.08K shares S-4/A · filed 2026-06-03 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 12.21K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | 5.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 12.21K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 15.26K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | 6.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 15.26K shares 10-K · filed 2025-03-06 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 12.18K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | 8.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 12.18K shares derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | 7.55K shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | 3.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | 7.55K shares 10-K · filed 2024-03-01 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | |
| 2022-06-30 | 3.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-11 | |
| 2021-09-30 | 42.99K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |